June 23, 2023 06:28 AM EDTUpdated 10:07 AM
Peer Review

Se­bas­t­ian Guth sharp­ens his fo­cus at Bay­er; As CD47 strug­gles per­sist, I-Mab ap­points CEO

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Bay­er is re­fin­ing Se­bas­t­ian Guth’s role on June 30, nam­ing him se­nior Bay­er rep­re­sen­ta­tive and pres­i­dent of Bay­er US. Guth …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times